Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison
PaperCitations, authors & open-access status
Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 16 citations, 2023 year and hybrid oa status.
16
Citations
2023
Year
hybrid
OA Status